Soleno Therapeutics, Inc. (SLNO), a developer of novel therapeutics for the treatment of rare diseases, said on Thursday that it has appointed Jennifer Fulk as Chief Financial Officer.
She will succeed James Mackaness, who will retire from the company by the end of the first quarter.
Fulk served as Chief Operating Officer and Chief Financial Officer of 120Water, Inc. from September 2024 through October 2025.
Previously, she served as Chief Financial Officer of Talkspace, Inc., a virtual behavioral healthcare company, from July 2021 to May 2024.
Fulk also spent over 15 years at Eli Lilly and Company in various finance executive roles, including Chief Financial Officer of U.S. Bio-Medicines.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.